Alyson L. Wooten, PharmD


Kilpatrick Townsend & Stockton LLP

Alyson Wooten, PharmD, focuses her practice on patent litigation with a special emphasis on pharmaceutical patent litigation under the Hatch-Waxman Act.  She has experience at all stages of the litigation process includes pre-filing investigations, discovery, expert witness preparation, Markman proceedings, dispositive motions, and settlement negotiations.  She has argued Markman hearings, summary judgment, and discovery-related hearings in various United States courts.  She also has experience in filing and conduct of Inter Partes Review proceedings, including proceedings co-pending with district court actions.

Registered as a patent attorney and pharmacist, Dr. Wooten also has broad experience in counseling clients on FDA regulatory matters, clinical trial management, early commercialization strategies, patent settlements and licenses regarding pharmaceuticals, drug product liability, and antitrust issues bearing on pharmaceutical patent settlements.  Prior to joining Kilpatrick Townsend, Dr. Wooten worked for a leading pharmaceutical company focusing on FDA regulatory matters, clinical trial program for investigational new drugs, and patent litigation under the Hatch-Waxman Act.

Dr. Wooten was recognized in 2017 and the six years immediately preceding as a Georgia "Rising Star" in the area of Intellectual Property Litigation by Super Lawyers magazine.